Kennedy Capital Management, Inc. Organogenesis Holdings Inc. Transaction History

Kennedy Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$3.14 - $6.43 $32,929 - $67,431	-10,487 Reduced 9.34%	101,782 $330,000
Q2 2022 Aug 10, 2022	SELL	$4.74 - $8.15 $5,128 - $8,818	-1,082 Reduced 0.95%	112,269 $548,000
Q1 2022 May 16, 2022	SELL	$6.47 - $9.57 $113,833 - $168,374	-17,594 Reduced 13.44%	113,351 $864,000
Q4 2021 Feb 14, 2022	BUY	$9.02 - $13.5 $1.18 Million - $1.77 Million	130,945 New	130,945 $1.21 Million

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $406M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.